Cargando…
Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case series
BACKGROUND AND AIM: It is still unclear whether patients with severe asthma are at greater risk of developing severe COVID-19, particularly pediatric allergic patients under biologic therapy. Studies targeting pediatric patients are currently limited; thus, this study aims to assess the clinical cha...
Autores principales: | Votto, Martina, Santi, Viola, Bajeli, Marta, De Filippo, Maria, Deidda, Elisa, De Stefano, Emanuela, Dianin, Francesco, Raviola, Chiara, Silvi, Cecilia, Marseglia, Gian Luigi, Licari, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494179/ https://www.ncbi.nlm.nih.gov/pubmed/35666117 http://dx.doi.org/10.23750/abm.v93iS3.13073 |
Ejemplares similares
-
Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review
por: Votto, Martina, et al.
Publicado: (2021) -
Association between treatment awareness and uncontrolled asthma in adolescents
por: Castagnoli, Riccardo, et al.
Publicado: (2022) -
Rapid response to dupilumab treatment in children with moderate‐to‐severe atopic dermatitis: A case series
por: Votto, Martina, et al.
Publicado: (2022) -
Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease?
por: Votto, Martina, et al.
Publicado: (2020) -
Non-invasive biomarkers of eosinophilic esophagitis
por: Votto, Martina, et al.
Publicado: (2021)